ENDOSCOPIC SLEEVE GASTROPLASTY USING THE ENDOMINA DEVICE AS A BRIDGE-TO SURGERY PROCEDURE FOR SUPEROBESE PATIENTS

Aims Endoscopic sleeve gastroplasty (ESG) is a minimally invasive bariatric procedure that reduces the gastric volume and delays gastric emptying to facilitate weight loss. The effectiveness and safety of ESG in weight loss has mainly been described for patients with class I and II obesity, but not routinely for superobese and high-risk patients. This study aims to evaluate the safety, feasibility, and efficacy of ESG for superobese and high-risk patients as a bridge to surgery (BTS) procedure.